International Cancer Centre of Jinshazhou Hospital of Guangzhou Medical University of Chinese Medicine
The International Cancer Centre of Jinshazhou Hospital of Guangzhou Medical University of Chinese Medicine (hereinafter referred to as: Centre) is a world-class oncology facility located in Guangzhou, southeast China.
The Centre is a joint-venture between Jinshazhou Hospital and the ICON Group, Australia’s leading cancer care service provider. The University of Wollongong in New South Wales, Australia also collaborates with the Centre to provide medical physics research, training and education.
The Centre’s team is led by internationally renowned medical physicist Dr Yang Wang. In addition to being the Director of the International Cancer Centre, Dr Wang is also Vice President of Jinshazhou Hospital of Guangzhou Medical University of Chinese Medicine, and Director of Radiotherapy Department, Chief Technology Executive Officer of Aodekang International, Professor of the University of Wollongong in Australia, visiting professor of Tsinghua University, an official member of Australian Society of Medical Physicists and American Society of Medical Physicists.
Dr Wang has worked in the anti-cancer field in China and Australia for more than 30 years. In the mid-1980s, he was part of the first team of medical physicists from China to travel to the Varian Headquarters in the United States for further education. He was responsible for importing the first Varian high-energy medical linear accelerator to be used in China, to the General Hospital of Beijing Railway Medical College.
In 1987, he travelled to Australia for further study where he earned his Master’s Degree and PhD successively. In 1990, he has employed at St. Vincent’s hospital as a medical physicist.
Dr Wang’s team at the Centre is comprised of 5 doctors, including 1 Chief Physician, 2 Deputy Chief Physicians, 2 Attending Physicians, 6 Physicists, including 1 Senior Admin, 4 Technicians and 12 Nurses. The long-term collaboration with Australia’s ICON Group has meant Australian experts regularly visit the Centre to add further consultation and guidance to the clinical work undertaken.
The Centre has a world-class medical imaging department that boasts some of the most cutting-edge equipment available anywhere in the world. These include:
- Varian TrueBeam and Halcyon Linear Accelerator
- Ankoray M6 full-digital radiosurgery knife
- Siemens SOMATOM Confidence four-dimensional large aperture CT analogue positioner
- Varian HDR/ LDR intracavity close-up irradiation radiotherapy equipment.
All equipment is supported by CT/MR/PET-CT imaging and carries out Static/Dynamic Radiation Therapy in all directions, including three-dimensional conformity, volumetric intensity, three-dimensional body-oriented radiosurgery, respiratory-gated radiation therapy, close-up brachytherapy and particle-implanted irradiation technologies.
Further confirmation that the International Cancer Centre is truly world-class, came with the recent announcement that Mevion Medical Systems will supply GSB with a Mevion S250i Proton Therapy System with HYPERSAN Pencil Beam Scanning – making it the first compact proton therapy system in the Guangdong-Hong Kong-Macau Greater Bay Area.
Proton therapy is an advanced form of radiation therapy that reduces unnecessary radiation to healthy tissue and prevents complications and secondary cancers. Mevion’s leading HYPERSCAN Pencil Beam Scanning technology further enhances these benefits with a faster and sharper dose delivery, which can be collimated layer-by-layer to deliver a more precise and conformal dose to the tumour.
“We are pleased to be partnering with Mevion to make proton therapy available to benefit cancer patients in South China,” said Wensheng Liu, President of Jinshazhou Hospital. “MEVION S250i system is the most advanced proton therapy system available today and represents the best overall proton therapy solution. Its addition will position Jinshazhou Hospital as a world-class radiation therapy centre. We look forward to elevating our cancer treatment, research capabilities, and medical education to the next level with protons.”
The new Mevion system is expected to be available for treatment in 2021.
The Centre employs a MDT (Multi-Disciplinary Team) model for diagnosis and tailoring treatment protocols for patients, which relies on the intensive collaboration and cooperation of experts from a range of specialist departments.
The MDT model consists of three phases:
- Preliminary MDT
- Consultation MDT
- MDT Patient Database
Preliminary MDT is a diagnosis and treatment model incorporating the combined ‘best-practice’ processes of Chinese and Australian oncology departments. When a new patient presents to the hospital with possible cancer symptoms, they will be referred to the MDT clinic in the Centre.
Here the consulting doctor will examine and interview the patient, before making some initial recommendations for testing, diagnosis and treatment, which will be entered into the MDT Patient Data Base and management system. Once the results have been received the MDT team will then collaborate (Consultation MDT) to confirm the diagnosis and best treatment plan moving forward for the patient.
Consultation MDT is the core of the MDT model, providing an advanced platform for interdisciplinary consultation of patients in treatment – sharing of ideas, resources and expertise. It organises the resources of medical experts for consultation, improves the efficiency of consultation (including remote consultation when necessary), improves the quality and academic nature of the consultation, and streamlines the interdisciplinary consultation from the management perspective – all which optimise the benefits to the patients.
The MDT Patient Database is the foundation of the MDT system. Here every detail of the patient’s vital information and medical history is entered, from their initial consultation through to their test results, referrals, treatment protocol, doctor’s notes, payment information and anything else relevant to that patient. It provides for the most efficient sharing and flow of information between all practitioners and departments, which ultimately results in improved patient experiences and outcomes.
Jinshazhou Hospital is also home to the world’s leading SPDT Clinic – SPDT 4 Life Holistic Cancer Treatment Centre. Located on the VIP 12th floor of the hospital, Dr Lucy Li and her team of SPDT experts provide an extensive range of holistic therapies that in combination with the International Cancer Centre resources, provide an unparalleled level of care and options for cancer patients around the world.
Most notably SPDT 4 LIFE has the only full-body SPDT equipment in the world, providing for patients with the metastatic disease a nontoxic, holistic alternative, which is so important to a large percentage of patients these days. SPDT 4 LIFE also offers HIFU, NanoKnife, Hyperbaric Oxygen Therapy, Hyperthermia, Traditional Chinese Medicine (TCM), Immunotherapy, Brachytherapy and an extensive range of holistic treatments including, exercise as medicine, gut health, diet/ nutritional advice, supplementation and mindfulness.
The team at SPDT 4 LIFE understand that cancer does not happen in isolation, so it makes no sense to treat cancer in insolation and ignore the patient’s overall health – which undoubtedly contributed to their cancer in the first place. Here the team will treat the patient’s cancer and also focus on returning them to optimal health, so they have the best chance of staving off any recurrence and living a long happy, healthy, fulfilled life.
Oncologist Zhang Wenying, is a Chief Physician that works in both the International Cancer Centre and SPDT 4 LIFE departments. Iris, as she is known, studied for a year at the Royal Hospital of Edinburgh and the Western General Hospital of Edinburgh. She is a member of the 1st Session of the Functional Medicine Professional Committee of China Medical and Health Development Foundation and has studied and engaged in clinical oncology and research related specialities, including SPDT, for many years.
Dr Zhang is experienced in the comprehensive diagnosis and treatment of multiple solid malignant tumours, mainly based on molecular targeting therapy and immunotherapy – especially for lung, breast, gastric, colorectal and ovarian cancers – using the MDT Model.
She also has the experience and is keenly interested in the more holistic ‘internationally recognised and accepted’ treatment concepts including exercise, nutrition, psychology and the impact the physical and mental environment has on a patient. She values highly open communication with patients, as it is key to enhancing their confidence in the treatment and improving their outcomes. She also considers it important to educate the patients, their families and the public in general, on holistic health practices, so they may stave off a recurrence and prevent others from ever developing cancer.
In a world where so many hospitals and cancer treatment centres are often limited to the standard chemotherapy, radiation and surgery, it is reassuring to know that the International Cancer Centre of Jinshazhou Hospital in conjunction with SPDT 4 LIFE can provide so much more. Patients around the world can come here when they are looking for a more comprehensive and wider range of treatment options and the incredible team of experts will tailor a program for each individual patient, leaving no stone unturned as they work to return them to optimal health.